Floridi, C <br/><br/>
Yttrium-90 radioembolization treatment for unresectable hepatocellular carcinoma: a single-centre prognostic factors analysis.  [electronic resource] 

 -  Medical oncology (Northwood, London, England)  Sep 2017 
 - 174 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1559-131X 
<br/><br/><label>Standard No.: </label>10.1007/s12032-017-1021-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Carcinoma, Hepatocellular--mortality<br/>Disease-Free Survival<br/>Embolization, Therapeutic--adverse effects<br/>Female<br/>Humans<br/>Kaplan-Meier Estimate<br/>Liver Neoplasms--mortality<br/>Male<br/>Middle Aged<br/>Prognosis<br/>Radiopharmaceuticals<br/>Treatment Outcome<br/>Yttrium Radioisotopes